Novavax, Inc. (NVAX) NASDAQ

10.21

-0.3(-2.85%)

Updated at June 02 04:00PM

Currency In USD

Valuation

Market Cap1.09B
Enterprise Value1.1B
P/E Ratio-18.98
PEG Ratio0.16
Price/Sales Ratio2.82
Price/Book Ratio-11.52
Enterprise/Revenue2.93
Enterprise/EBITDA-30.62

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.15
Operating Margin-0.11

Management Effectiveness

Return On Assets-0.08
Return On Equity0.9

Income Statement

Revenue1.12B
Revenue/Share3.65
Gross Profit1.05B
EBITDA492.33M
Net Income440.3M
Diluted EPS2.54

Balance Sheet

Total Cash790.33M
Total Cash/Share4.84
Total Debt295.06M
Total Debt/Equity-2.04
Current Ratio2.48
Book Value Per Share-0.89

Price History

52-Week Change40.63
52-Week High11.97
52-Week Low6.13
Moving Average 50 Days8.87
Moving Average 200 Days8.4

Statistics

Average Volume4.62M
Shares Outstanding164.44M
% Held by Institutions72.84

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateMay 10, 2019